Answers are grounded in this paper and cite their sources.
Expanding the XLH Matters programmeXLH Matters has become one of the 'go-to' annual meetings held in Europe for healthcare professionals (HCPs) from a wide range of specialties, across geographical regions, who treat people living with XLH.This programme brings HCPs together to hear about the latest research, discuss current clinical challenges and share experiences to inspire local practice and improve patient outcomes.A comprehensive summary of the key findings from XLH Matters 2022 is available in 'XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)' [1].The key objectives of the XLH Matters programme are listed in Box 1.
No takes yet. Share an insight, caveat, or question.
Seefried et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: